Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Revenue (2017 - 2025)

Historic Revenue for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $269.1 million.

  • Inspire Medical Systems' Revenue rose 1224.73% to $269.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $912.0 million, marking a year-over-year increase of 1359.95%. This contributed to the annual value of $912.0 million for FY2025, which is 1359.95% up from last year.
  • Latest data reveals that Inspire Medical Systems reported Revenue of $269.1 million as of Q4 2025, which was up 1224.73% from $224.5 million recorded in Q3 2025.
  • Inspire Medical Systems' Revenue's 5-year high stood at $269.1 million during Q4 2025, with a 5-year trough of $40.4 million in Q1 2021.
  • Its 5-year average for Revenue is $149.0 million, with a median of $152.2 million in 2023.
  • Per our database at Business Quant, Inspire Medical Systems' Revenue skyrocketed by 33469.59% in 2021 and then surged by 1048.77% in 2025.
  • Over the past 5 years, Inspire Medical Systems' Revenue (Quarter) stood at $78.4 million in 2021, then soared by 75.9% to $137.9 million in 2022, then surged by 39.6% to $192.5 million in 2023, then increased by 24.52% to $239.7 million in 2024, then rose by 12.25% to $269.1 million in 2025.
  • Its last three reported values are $269.1 million in Q4 2025, $224.5 million for Q3 2025, and $217.1 million during Q2 2025.